685 related articles for article (PubMed ID: 15804465)
21. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Intra M; Rotmensz N; Veronesi P; Colleoni M; Iodice S; Paganelli G; Viale G; Veronesi U
Ann Surg; 2008 Feb; 247(2):315-9. PubMed ID: 18216539
[TBL] [Abstract][Full Text] [Related]
23. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
[TBL] [Abstract][Full Text] [Related]
24. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
26. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
27. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
28. [Ductal carcinoma in situ (DCIS) and biopsy of the sentinel lymph node].
Chvalný P; Donát R; Dyttert D; Siska D; Sabol M; Králik R; Mracna P; Malina J; Veselý J; Duchaj B; Cích D; Lehotská V; Rauová K; Smreková M; Galbavý S; Macák D; Macháleková K; Bokes T
Rozhl Chir; 2011 Jun; 90(6):352-60. PubMed ID: 22026103
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
30. The use of sentinel lymph node biopsy in ductal carcinoma in situ.
Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W
Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS).
Price A; Schnabel F; Chun J; Kaplowitz E; Goodgal J; Guth A; Axelrod D; Shapiro R; Mema E; Moy L; Darvishian F; Roses D
Breast J; 2020 May; 26(5):931-936. PubMed ID: 31957944
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Prendeville S; Ryan C; Feeley L; O'Connell F; Browne TJ; O'Sullivan MJ; Bennett MW
Breast; 2015 Jun; 24(3):197-200. PubMed ID: 25681861
[TBL] [Abstract][Full Text] [Related]
33. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
34. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
35. The utility of sentinel lymph node biopsy in patients with ductal carcinoma in situ suspicious for microinvasion on core biopsy.
Namm JP; Mueller J; Kocherginsky M; Kulkarni S
Ann Surg Oncol; 2015 Jan; 22(1):59-65. PubMed ID: 25063009
[TBL] [Abstract][Full Text] [Related]
36. The role of sentinel lymph node biopsy in ductal carcinoma in situ.
Moran CJ; Kell MR; Kerin MJ
Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of Van Nuys Prognostic Index as a qualification criterion to sentinel lymph node biopsy in patients diagnosed with ductal carcinoma in situ.
Nowikiewicz T; Wiśniewska M; Wiśniewski M; Zegarski W
Pol Przegl Chir; 2015 Feb; 86(10):479-85. PubMed ID: 25720107
[TBL] [Abstract][Full Text] [Related]
38. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
39. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
Ballehaninna UK; Chamberlain RS
Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
[TBL] [Abstract][Full Text] [Related]
40. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
Yi M; Krishnamurthy S; Kuerer HM; Meric-Bernstam F; Bedrosian I; Ross MI; Ames FC; Lucci A; Hwang RF; Hunt KK
Am J Surg; 2008 Jul; 196(1):81-7. PubMed ID: 18436181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
